مهمان عزیز شما حق دیدن لینک ها را ندارید برای استفاده از امکانات کامل انجمن عضو شوید

عضویت

Intermediate surrogate markers are urgently required to enable timely assessment of the efficacy of potential new breast cancer preventive drugs, particularly in women at high risk of the disease so as not to substantially delay or preclude bilateral mastectomy that is a safe risk reducing option